| Grigor Michael Harutunian, MD | |
|
1215 S Central Ave, Glendale, CA 91204-2503 | |
| (818) 937-9944 | |
| Not Available |
| Full Name | Grigor Michael Harutunian |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 16 Years |
| Location | 1215 S Central Ave, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568692101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | A111421 (California) | Primary |
| 2084N0600X | Psychiatry & Neurology - Clinical Neurophysiology | A111421 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Glendale Mem Hospital & Hlth Center | Glendale, CA | Hospital |
| Entity Name | Grigor M. Harutunian, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851737738 PECOS PAC ID: 0345488029 Enrollment ID: O20130608000177 |
News Archive
The Journal of Pathology recently published a paper entitled Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. The study looked at 12,674 stored appendix and tonsil samples, and found that 3 of them showed evidence of the prion protein associated with variant Creutzfeldt-Jakob Disease (vCJD).
Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
No treatment or vaccine currently exists for Zika virus. For most people who contract the virus, the illness will be mild and pass on its own in about one week.
On 29 July, the Directors-General of the World Health Organization, the World Intellectual Property Organization and the WTO presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grigor Michael Harutunian, MD 1215 S Central Ave, Glendale, CA 91204-2503 Ph: (818) 937-9944 | Grigor Michael Harutunian, MD 1215 S Central Ave, Glendale, CA 91204-2503 Ph: (818) 937-9944 |
News Archive
The Journal of Pathology recently published a paper entitled Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. The study looked at 12,674 stored appendix and tonsil samples, and found that 3 of them showed evidence of the prion protein associated with variant Creutzfeldt-Jakob Disease (vCJD).
Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.
Genzyme Corp. announced today that ongoing discussions with Sanofi-Aventis have progressed to the point where Genzyme's board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis in order to allow Sanofi to conduct due diligence. Discussions between Genzyme's advisors and Sanofi's advisors and between Genzyme and Sanofi representatives are continuing.
No treatment or vaccine currently exists for Zika virus. For most people who contract the virus, the illness will be mild and pass on its own in about one week.
On 29 July, the Directors-General of the World Health Organization, the World Intellectual Property Organization and the WTO presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation.
› Verified 3 days ago
Miss Tiffany Yan Cao, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1510 S Central Ave Ste 600, Glendale, CA 91204 Phone: 818-630-6085 | |
Artin Minaeian, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1451 E Chevy Chase Dr Ste 201, Glendale, CA 91206 Phone: 818-265-2245 Fax: 877-575-9782 | |
Ara D Kadoyan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1560 E Chevy Chase Dr Suite #340, Glendale, CA 91206 Phone: 818-244-9367 Fax: 818-956-7664 | |
Amaiak Chilingaryan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 S Central Ave, 307, Glendale, CA 91204 Phone: 818-646-1414 Fax: 818-646-1441 | |
Dr. Armen J. Cherik, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1215 S Central Ave, Glendale, CA 91204 Phone: 818-241-1911 | |
Mrs. Anahit G Matevosyan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 N Brand Blvd Ste 630, Glendale, CA 91203 Phone: 818-476-0132 Fax: 818-476-0119 | |
Dr. Arakel Davtian, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 222 W Eulalia St, 301, Glendale, CA 91204 Phone: 818-240-0108 |